|
It was reported that a patient underwent an orthopedic procedure on (b)(6) 2023 and a barbed suture was used.During the procedure, before use, it was noticed that the fixation tab was broken.There were no adverse consequences to the patient.Upon evaluation of the returned device, the sides of the fixation tab were found to be broken.
|
|
(b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.H3 investigation summary: the product was returned to ethicon for evaluation.Visual inspection was conducted on the returned device.The returned sample determined that it was received one open sample that pertained to the product code sxpp1a300.During the visual assessment of the needle suture, it was noted that the swage and attachment area were as expected.Marks on the body needle that appears to be caused by a surgical instrument could be observed.The suture was examined, body fluids at some barbs were found and the sides of the fixation tab were found to be broken.It should be noted that a 100% inspection is performed via the automotive vision system to ensure the tab is present and complete during manufacturing.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.
|